Regulation of immunity during visceral Leishmania infection
V Rodrigues, A Cordeiro-da-Silva, M Laforge… - Parasites & vectors, 2016 - Springer
Unicellular eukaryotes of the genus Leishmania are collectively responsible for a
heterogeneous group of diseases known as leishmaniasis. The visceral form of …
heterogeneous group of diseases known as leishmaniasis. The visceral form of …
Chemotherapy of leishmaniasis
SL Croft, V Yardley - Current pharmaceutical design, 2002 - ingentaconnect.com
Leishmaniasis, in its variety of visceral (VL), cutaneous (CL) and mucocutaneous (MCL)
forms, directly affects about 2 million people per annum, with approximately 350 million …
forms, directly affects about 2 million people per annum, with approximately 350 million …
[图书][B] Pocket companion to Robbins and Cotran pathologic basis of disease
RN Mitchell - 2006 - books.google.com
This pocket-sized resource offers rapid, portable access to the most important facts and
concepts from Robbins and Cotran Pathologic Basis of Disease, 7th Edition. It is a superb …
concepts from Robbins and Cotran Pathologic Basis of Disease, 7th Edition. It is a superb …
Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.
JM Burns Jr, WG Shreffler, DR Benson… - Proceedings of the …, 1993 - National Acad Sciences
We report the cloning of a Leishmania chagasi antigen gene and an evaluation of
leishmaniasis patient antibody responses to the recombinant protein, rK39. rK39 contains a …
leishmaniasis patient antibody responses to the recombinant protein, rK39. rK39 contains a …
Laboratory diagnosis of cutaneous and visceral leishmaniasis: current and future methods
Leishmaniasis is a neglected tropical disease with two main clinical forms: cutaneous and
visceral leishmaniasis. Diagnosis of leishmaniasis is still a challenge, concerning the …
visceral leishmaniasis. Diagnosis of leishmaniasis is still a challenge, concerning the …
Immunology of leishmaniasis
FY Liew, CA O'donnell - Advances in parasitology, 1993 - Elsevier
Publisher Summary This chapter discusses the role of the immune response to Leishmania,
with particular reference to the cutaneous disease caused by L. major. Leishmaniasis is …
with particular reference to the cutaneous disease caused by L. major. Leishmaniasis is …
Leishmania/HIV co-infections in the second decade
Leishmania-HIV co-infection has been globally controlled in Southern Europe since 1997
because of highly active anti retroviral therapy (HAART), but it appears to be an increasing …
because of highly active anti retroviral therapy (HAART), but it appears to be an increasing …
Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs
Leishmaniasis is a disease complex caused by 20 species of protozoan parasites belonging
to the genus Leishmania. In humans, it has two main clinical forms, visceral leishmaniasis …
to the genus Leishmania. In humans, it has two main clinical forms, visceral leishmaniasis …
Serodiagnosis of leishmaniasis
K Kar - Critical reviews in microbiology, 1995 - Taylor & Francis
Leishmaniasis is a spectrum of diseases ranging in severity from cutaneous (CL), post-kala-
azar dermal (PKDL), and diffuse cutaneous (DCL) to mucocutaneous (MCL) and visceral …
azar dermal (PKDL), and diffuse cutaneous (DCL) to mucocutaneous (MCL) and visceral …
Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis
JP Haldar, S Ghose, KC Saha, AC Ghose - Infection and immunity, 1983 - Am Soc Microbiol
Cell-mediated immune (CMI) response in 16 Indian kala-azar (KA) and 12 post-kala-azar
dermal leishmaniasis (PKADL) patients was studied in detail by in vitro lymphocyte …
dermal leishmaniasis (PKADL) patients was studied in detail by in vitro lymphocyte …